Renalytix
People in the News at Agilent Technologies, ASHG, Veracyte, Enzo Biochem, Renalytix, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Sept. 4, 2023
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
Renalytix Posts $2.9M in Revenue for Fiscal 2022
The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.
The 2020 spinout from UK firm Renalytix is launching an acute rejection risk test, with two other transplant tests expected to launch within the next two years.
In Brief This Week: Cardea Bio, Proof Diagnostics, Ginkgo Bioworks, Twist Bioscience, More
News items for the week of April 4, 2022.